Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

Olivier Hermine; Xavier Mariette; Raphael Porcher; Felix Djossou; Yann Nguyen; Jean-Benoît Arlet; Laurent Savale; Jean Luc Diehl; Sophie Georgin-Lavialle; Jacques Cadranel; Gilles Pialoux; Karine Lacombe; Arsène Mekinian; Hélène Gros; Xavier Lescure; Jade Ghosn; Elisabeth Coupez; Kevin Grapin; Christophe Rapp; Marc Michel; Anne Lise Lecapitaine; Jean Marie Michot; Nathalie Costedoat-Chalumeau; Liem Binh Luong Nguyen; Luca Semerano; François Raffi; Claire Aguillar; Claire Rouzaud; Jacques Eric Gottenberg; Yves Hansmann; Boris Bienvenu; Jonathan London; Franklin Samou Fantchou; Felix Ackermann; Antoine Gros; Alexandre Morel; Nicolas Gambier; Damien Sène; Bruno Mégarbane; Elie Azoulay; Serge Bureau; Maxime Dougados; Joseph Emmerich; Muriel Fartoukh; Bertrand Guidet; Marc Humbert; Mathieu Mahevas; Frédéric Pène; Frédéric Schlemmer; Valérie Pourcher-Martinez; Annick Tibi; Gabriel Baron; Elodie Perrodeau; Stéphanie Baron; Gabriel Steg; Yazdan Yazdapanah; Tabassome Simon; Matthieu Resche-Rigon; Pierre-Louis Tharaux; Philippe Ravaud

EClinicalMedicine (2022) - Comments
pubmed: 35350097 doi: 10.1016/j.eclinm.2022.101362 issn: 2589-5370

Olivier Hermine, Xavier Mariette, Raphael Porcher, Felix Djossou, Yann Nguyen, Jean-Benoît Arlet, Laurent Savale, Jean Luc Diehl, Sophie Georgin-Lavialle, Jacques Cadranel, Gilles Pialoux, Karine Lacombe, Arsène Mekinian, Hélène Gros, Xavier Lescure, Jade Ghosn, Elisabeth Coupez, Kevin Grapin, Christophe Rapp, Marc Michel